Gabriel Cea
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Gabriel Cea has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Juan Pablo Contreras
Departamento de Ciencias Neurologicas Oriente Facultad de Medicina, Universidad de Chile Santiago Chile
3 shared publications Rodrigo Salinas
Departamento de Ciencias Neurológicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile
3 shared publicationsDaniel Andreu
Departamento de Ciencias Neurológicas, Universidad de Chile, Santiago, Chile
2 shared publicationsElaine Fletcher
Department of Clinical Genetics, Centre for Genomic and Experimental Medicine, Western General Hospital, Edinburgh, EH5 2GL, UK
2 shared publications- Emma Matthews
Atkinson-Morley Neuromuscular Centre, Department of Neurology, St George’s University Hospitals NHS Foundation Trust, and Department of Psychology and Neuroscience, St George’s School of Health and Medical Sciences, City St George’s, University of London Cranmer Terrace, London, UK
2 shared publications Gonzalo Guajardo
Hospital San Camilo. San Felipe, Chile
2 shared publications
Latest Publications
- Open Access
- 1 December 2021
- Published by SciELO Agencia Nacional de Investigacion y Desarrollo (ANID) in Revista médica de Chile
- Vol. 149 (12) , 1812-1816
Guillain-Barré syndrome in patients with SARS-CoV-2 infection. Report of three cases
Several cases of Guillain Barre Syndrome (GBS) associated with SARS-CoV-2 have been published, most being acute inflammatory demyelinating polyradiculoneuropathy. Between April and December 2020, 1,499 cases of SARS-CoV-2 infection were admitted to Hospital del Salvador, in Santiago, Chile, serving a population of 521,920 adults. In the same period, seven cases of GBS were admitted. Three females had a demyelinated type of GBS associated with SARS-CoV-2 infection. All three presented with progressive flaccid symmetrical areflexic weakness with inability to walk, one needed intubation and mechanical ventilation due to SARS-CoV2 infection. All had a favorable, rapid response to intravenous immunoglobulin. In two patients, the onset of GBS was almost concomitant with SARS-CoV-2 infection. A causal relationship between SARS-CoV-2 and GBS has been questioned since no increase of GBS has occurred during the pandemic. However, a rise in GBS associated with SARS-CoV-2 infection could be hidden due to a general decrease of GBS due to the decrease of all other infections. Lack of reporting due to the pandemic could be an added factor.
- 1 December 2021
- Published by SciELO Agencia Nacional de Investigacion y Desarrollo (ANID) in Revista médica de Chile
- Vol. 149 (12) , 1812-1816
Open AccessGuillain-Barré syndrome in patients with SARS-CoV-2 infection. Report of three cases
Several cases of Guillain Barre Syndrome (GBS) associated with SARS-CoV-2 have been published, most being acute inflammatory demyelinating polyradiculoneuropathy. Between April and December 2020, 1,499 cases of SARS-CoV-2 infection were admitted to Hospital del Salvador, in Santiago, Chile, serving a population of 521,920 adults. In the same period, seven cases of GBS were admitted. Three females had a demyelinated type of GBS associated with SARS-CoV-2 infection. All three presented with progressive flaccid symmetrical areflexic weakness with inability to walk, one needed intubation and mechanical ventilation due to SARS-CoV2 infection. All had a favorable, rapid response to intravenous immunoglobulin. In two patients, the onset of GBS was almost concomitant with SARS-CoV-2 infection. A causal relationship between SARS-CoV-2 and GBS has been questioned since no increase of GBS has occurred during the pandemic. However, a rise in GBS associated with SARS-CoV-2 infection could be hidden due to a general decrease of GBS due to the decrease of all other infections. Lack of reporting due to the pandemic could be an added factor.
- 15 June 2021
- Published by Wiley in Acta Neurologica Scandinavica
- Vol. 144 (5) , 546-552
Validation of Spanish version of 15‐item myasthenia gravis quality‐of‐life questionnaire
Objectives The aim of this study was to achieve the translation and cross-cultural adaptation of the MG-QOL15R questionnaire into Spanish and the analysis of its psychometric properties. Materials and Methods We recruited patients with MG, ≥18 years old, whose mother tongue was Spanish. After the translation and cross-cultural adaptation of the MG-QOL15-R, the following tests were performed: internal consistency using the Cronbach-α coefficient and corrected item-total correlations; reproducibility with a test-retest analysis using intraclass correlation coefficients; and concurrent validity using Spearman's correlation coefficient of the Spanish language MG-QOL15R-S, Myasthenia Gravis Activity of Daily Living (MG-ADL) and Quantitative Myasthenia Gravis (QMG) scores. As an approximation to construct validity, the nonparametric Mann-Whitney U test was performed between MG-QOL15R-S scores according to the Myasthenia Gravis Foundation of America classification. Results A total of 83 MG patients were enrolled, mean age 48.19 ± 17.25 years; 58 (69.9%) were women. The mean MG-QOL15R-S score was 11.3 ± 7.1. Cronbach-α coefficient was 0.92. Item-total correlation ranged between 0.43 and 0.75. Intraclass correlation coefficient was 0.80. The Spearman correlation coefficient was 0.637 (p-value < .001) for MG-ADL and 0.487 (p-value < .001) for QMG. Mann-Whitney U tests of the mean MG-QOL15R-S scores were significantly different according to the clinical severity (p-value < .001). Conclusions The Spanish version of the MG-QOL15R is a valid and reliable instrument and potentially useful for measuring health-related quality of life in Spanish-speaking MG patients.
- 15 June 2021
- Published by Wiley in Acta Neurologica Scandinavica
- Vol. 144 (5) , 546-552
Validation of Spanish version of 15‐item myasthenia gravis quality‐of‐life questionnaire
Objectives The aim of this study was to achieve the translation and cross-cultural adaptation of the MG-QOL15R questionnaire into Spanish and the analysis of its psychometric properties. Materials and Methods We recruited patients with MG, ≥18 years old, whose mother tongue was Spanish. After the translation and cross-cultural adaptation of the MG-QOL15-R, the following tests were performed: internal consistency using the Cronbach-α coefficient and corrected item-total correlations; reproducibility with a test-retest analysis using intraclass correlation coefficients; and concurrent validity using Spearman's correlation coefficient of the Spanish language MG-QOL15R-S, Myasthenia Gravis Activity of Daily Living (MG-ADL) and Quantitative Myasthenia Gravis (QMG) scores. As an approximation to construct validity, the nonparametric Mann-Whitney U test was performed between MG-QOL15R-S scores according to the Myasthenia Gravis Foundation of America classification. Results A total of 83 MG patients were enrolled, mean age 48.19 ± 17.25 years; 58 (69.9%) were women. The mean MG-QOL15R-S score was 11.3 ± 7.1. Cronbach-α coefficient was 0.92. Item-total correlation ranged between 0.43 and 0.75. Intraclass correlation coefficient was 0.80. The Spearman correlation coefficient was 0.637 (p-value < .001) for MG-ADL and 0.487 (p-value < .001) for QMG. Mann-Whitney U tests of the mean MG-QOL15R-S scores were significantly different according to the clinical severity (p-value < .001). Conclusions The Spanish version of the MG-QOL15R is a valid and reliable instrument and potentially useful for measuring health-related quality of life in Spanish-speaking MG patients.
- 4 June 2021
- Published by Wiley in Muscle & Nerve
- Vol. 64 (2) , 123-124
Antibiotics in myasthenia gravis: Thinking outside the black box
- 4 June 2021
- Published by Wiley in Muscle & Nerve
- Vol. 64 (2) , 123-124
Antibiotics in myasthenia gravis: Thinking outside the black box
- Open Access
- 12 May 2020
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 5, 57
Sodium channel myotonia may be associated with high-risk brief resolved unexplained events
Brief resolved unexplained events (BRUEs) have numerous and varied causes posing a challenge to investigation and management. A subset of infants with the neuromuscular disorder sodium channel myotonia, due to mutations in the SCN4A gene, experience apnoeic events due to laryngospasm (myotonia) of the upper airway muscles that may present as a BRUE. We sought to ascertain the frequency, severity and outcome of infants carrying the G1306E SCN4A mutation commonly associated with this presentation. We report 14 new cases of individuals with the G1306E mutation from three unrelated families and perform a literature review of all published cases. Infants with the G1306E mutation almost universally experience laryngospasm and apnoeic events. The severity varies significantly, spans both low and high-risk BRUE categories or can be more severe than criteria for a BRUE would allow. At least a third of cases require intensive care unit (ICU) care. Seizure disorder is a common erroneous diagnosis. Apnoeas are effectively reduced or abolished by appropriate treatment with anti-myotonic agents. Probands with the G1306E mutation who are family planning need to be counselled for the likelihood of post-natal complications. There is readily available and extremely effective treatment for the episodic laryngospasm and apnoea caused by this mutation. Proactively seeking clinical evidence of myotonia or muscle hypertrophy with consideration of CK,EMG and genetic testing in high risk BRUEs or more complex apnoeic events may reduce avoidable and prolonged ICU admissions, patient morbidity and potentially mortality.
- 12 May 2020
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 5, 57
Open AccessSodium channel myotonia may be associated with high-risk brief resolved unexplained events
Brief resolved unexplained events (BRUEs) have numerous and varied causes posing a challenge to investigation and management. A subset of infants with the neuromuscular disorder sodium channel myotonia, due to mutations in the SCN4A gene, experience apnoeic events due to laryngospasm (myotonia) of the upper airway muscles that may present as a BRUE. We sought to ascertain the frequency, severity and outcome of infants carrying the G1306E SCN4A mutation commonly associated with this presentation. We report 14 new cases of individuals with the G1306E mutation from three unrelated families and perform a literature review of all published cases. Infants with the G1306E mutation almost universally experience laryngospasm and apnoeic events. The severity varies significantly, spans both low and high-risk BRUE categories or can be more severe than criteria for a BRUE would allow. At least a third of cases require intensive care unit (ICU) care. Seizure disorder is a common erroneous diagnosis. Apnoeas are effectively reduced or abolished by appropriate treatment with anti-myotonic agents. Probands with the G1306E mutation who are family planning need to be counselled for the likelihood of post-natal complications. There is readily available and extremely effective treatment for the episodic laryngospasm and apnoea caused by this mutation. Proactively seeking clinical evidence of myotonia or muscle hypertrophy with consideration of CK,EMG and genetic testing in high risk BRUEs or more complex apnoeic events may reduce avoidable and prolonged ICU admissions, patient morbidity and potentially mortality.
- 1 April 2020
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 74, 271-273
Epidemiology of chronic inflammatory demyelinating polyneuropathy in the South-Eastern area of Santiago, Chile
- 1 April 2020
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 74, 271-273
Epidemiology of chronic inflammatory demyelinating polyneuropathy in the South-Eastern area of Santiago, Chile
- Open Access
- 31 March 2020
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 5, 57
Sodium channel myotonia may be associated with high-risk brief resolved unexplained events
Brief resolved unexplained events (BRUEs) have numerous and varied causes posing a challenge to investigation and management. A subset of infants with the neuromuscular disorder sodium channel myotonia, due to mutations in the SCN4A gene, experience apnoeic events due to laryngospasm (myotonia) of the upper airway muscles that may present as a BRUE. We sought to ascertain the frequency, severity and outcome of infants carrying the G1306E SCN4A mutation commonly associated with this presentation. We report 12 new cases of individuals with the G1306E mutation from three unrelated families and perform a literature review of all published cases. Infants with the G1306E mutation almost universally experience laryngospasm and apnoeic events. The severity varies significantly, spans both low and high-risk BRUE categories or can be more severe than criteria for a BRUE would allow. At least a third of cases require intensive care unit (ICU) care. Seizure disorder is a common erroneous diagnosis. Apnoeas are effectively reduced or abolished by appropriate treatment with anti-myotonic agents. Probands with the G1306E mutation who are family planning need to be counselled for the likelihood of post-natal complications. There is readily available and extremely effective treatment for the episodic laryngospasm and apnoea caused by this mutation. Proactively seeking clinical evidence of myotonia or muscle hypertrophy with consideration of CK and EMG in high risk BRUEs or more complex apnoeic events may reduce avoidable and prolonged ICU admissions, patient morbidity and potentially mortality.
- 31 March 2020
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 5, 57
Open AccessSodium channel myotonia may be associated with high-risk brief resolved unexplained events
Brief resolved unexplained events (BRUEs) have numerous and varied causes posing a challenge to investigation and management. A subset of infants with the neuromuscular disorder sodium channel myotonia, due to mutations in the SCN4A gene, experience apnoeic events due to laryngospasm (myotonia) of the upper airway muscles that may present as a BRUE. We sought to ascertain the frequency, severity and outcome of infants carrying the G1306E SCN4A mutation commonly associated with this presentation. We report 12 new cases of individuals with the G1306E mutation from three unrelated families and perform a literature review of all published cases. Infants with the G1306E mutation almost universally experience laryngospasm and apnoeic events. The severity varies significantly, spans both low and high-risk BRUE categories or can be more severe than criteria for a BRUE would allow. At least a third of cases require intensive care unit (ICU) care. Seizure disorder is a common erroneous diagnosis. Apnoeas are effectively reduced or abolished by appropriate treatment with anti-myotonic agents. Probands with the G1306E mutation who are family planning need to be counselled for the likelihood of post-natal complications. There is readily available and extremely effective treatment for the episodic laryngospasm and apnoea caused by this mutation. Proactively seeking clinical evidence of myotonia or muscle hypertrophy with consideration of CK and EMG in high risk BRUEs or more complex apnoeic events may reduce avoidable and prolonged ICU admissions, patient morbidity and potentially mortality.
- Open Access
- 1 June 2019
- Published by SciELO Agencia Nacional de Investigacion y Desarrollo (ANID) in Revista médica de Chile
- Vol. 147 (6) , 803-807
Meningitis crónica autoinmune secundaria a meningitis aguda por neumococo. Caso clínico
Clásicamente, el neumococo llega al SNC cruzando la barrera hematoencefálica de manera encubierta; las bacterias activarían proteínas estreptococales que interactuarían con receptores de los linfocitos CD46, logrando su endocitocis con la ayuda de factores plaquetarios3. El ingreso del neumococo al SNC genera una respuesta inflamatoria en las meninges y en la pared vascular de medianas arterias y venas. El 97% de los pacientes con meningitis neumocócica, que tienen estudio neuropatológico, muestran arteritis o flebitis de los vasos cerebrales4. Estas arteriopatías pueden expresarse como infartos imagenológicos en 6% de los pacientes, quienes concomitantemente pueden desarrollar hemorragias o trombosis venosas3,4. También es muy frecuente la inflamación parenquimatosa difusa, como la cerebritis y más eventuales, las reacciones de estructuras ependimarias o ventriculares4. Esta amplia actividad inflamatoria que produce el neumococo dentro del SNC corresponde a respuestas ampliadas del sistema inmune en las infecciones neumocócicas, condición que podría generar una reactividad inmunológica tardía, capaz de inducir el desarrollo de vasculitis crónicas en las etapas postagudas de la infección5-7. Reactividad que ha sido interpretada como la perpetuación de una cascada inflamatoria independiente, causada por la desregulación en la especificidad inmunológica en ciertos pacientes6,8. La misma línea inmunológica ostentaría la meningitis crónica postinfección. Otra complicación infrecuente es el aumento del volumen ventricular que se observa en 2% de los pacientes2.
- 1 June 2019
- Published by SciELO Agencia Nacional de Investigacion y Desarrollo (ANID) in Revista médica de Chile
- Vol. 147 (6) , 803-807
Open AccessMeningitis crónica autoinmune secundaria a meningitis aguda por neumococo. Caso clínico
Clásicamente, el neumococo llega al SNC cruzando la barrera hematoencefálica de manera encubierta; las bacterias activarían proteínas estreptococales que interactuarían con receptores de los linfocitos CD46, logrando su endocitocis con la ayuda de factores plaquetarios3. El ingreso del neumococo al SNC genera una respuesta inflamatoria en las meninges y en la pared vascular de medianas arterias y venas. El 97% de los pacientes con meningitis neumocócica, que tienen estudio neuropatológico, muestran arteritis o flebitis de los vasos cerebrales4. Estas arteriopatías pueden expresarse como infartos imagenológicos en 6% de los pacientes, quienes concomitantemente pueden desarrollar hemorragias o trombosis venosas3,4. También es muy frecuente la inflamación parenquimatosa difusa, como la cerebritis y más eventuales, las reacciones de estructuras ependimarias o ventriculares4. Esta amplia actividad inflamatoria que produce el neumococo dentro del SNC corresponde a respuestas ampliadas del sistema inmune en las infecciones neumocócicas, condición que podría generar una reactividad inmunológica tardía, capaz de inducir el desarrollo de vasculitis crónicas en las etapas postagudas de la infección5-7. Reactividad que ha sido interpretada como la perpetuación de una cascada inflamatoria independiente, causada por la desregulación en la especificidad inmunológica en ciertos pacientes6,8. La misma línea inmunológica ostentaría la meningitis crónica postinfección. Otra complicación infrecuente es el aumento del volumen ventricular que se observa en 2% de los pacientes2.
- Open Access
- 1 June 2019
- Published by SciELO Agencia Nacional de Investigacion y Desarrollo (ANID) in Revista médica de Chile
- Vol. 147 (6) , 799-802
Síndrome de persona rígida confundido por trastorno conversivo: un error común. Caso clínico
Stiff-person syndrome is characterized by persistent muscle spasms, involving agonist and antagonist muscles simultaneously, starting in the lower limbs and trunk. It tends to occur in the fourth to sixth decade of life, presenting with intermittent spasms that later become continuous and usually painful. Minor sensory stimuli, such as noise or light touch, precipitate severe spasms. Spasms do not occur during sleep and only rarely involve cranial muscles. We present a case that for two years was diagnosed and treated as a conversion disorder associated with depression. After two years she was admitted to another hospital with an unmistakable picture of stiff-person syndrome with hypertrophy and rigidity of lower limb muscles, compatible electrophysiology and positive anti-GAD antibodies. She had autoimmune hypothyroidism, that should have raised the suspicion of stiff-person syndrome earlier. She responded to intravenous immunoglobulin and mycophenolate mofetil and and to tranquilizers that have muscle relaxant properties.
- 1 June 2019
- Published by SciELO Agencia Nacional de Investigacion y Desarrollo (ANID) in Revista médica de Chile
- Vol. 147 (6) , 799-802
Open AccessSíndrome de persona rígida confundido por trastorno conversivo: un error común. Caso clínico
Stiff-person syndrome is characterized by persistent muscle spasms, involving agonist and antagonist muscles simultaneously, starting in the lower limbs and trunk. It tends to occur in the fourth to sixth decade of life, presenting with intermittent spasms that later become continuous and usually painful. Minor sensory stimuli, such as noise or light touch, precipitate severe spasms. Spasms do not occur during sleep and only rarely involve cranial muscles. We present a case that for two years was diagnosed and treated as a conversion disorder associated with depression. After two years she was admitted to another hospital with an unmistakable picture of stiff-person syndrome with hypertrophy and rigidity of lower limb muscles, compatible electrophysiology and positive anti-GAD antibodies. She had autoimmune hypothyroidism, that should have raised the suspicion of stiff-person syndrome earlier. She responded to intravenous immunoglobulin and mycophenolate mofetil and and to tranquilizers that have muscle relaxant properties.
- Open Access
- 1 May 2019
- Published by SciELO Agencia Nacional de Investigacion y Desarrollo (ANID) in Revista médica de Chile
- Vol. 147 (5) , 658-662
Xantomatosis cerebrotendinosa sin xantomas tendíneos. Caso clínico
Cerebrotendinous xanthomatosis (CTX) is an uncommon autosomal recessive disease caused by deficiency of 27-sterol-hydroxylase that results in an accumulation of cholestanol in the central nervous system, eyes, tendons, and blood vessels. We report a 22-year-old woman with a history of cataract surgery at the age of 14, cholecystectomy due to cholelithiasis at the age of 17 and chronic diarrhea, who presented with a six months period of gait instability and frequent falls. Physical examination revealed a bilateral pyramidal and cerebellar syndrome, with no visible tendon xanthomas. Cerebral magnetic resonance imaging showed an increase of the signal intensity on the T2-weighted images in periventricular cerebral white matter, dentate nuclei and spinal cord. With a high suspicion of CXT, a genetic study was conducted identifying a pathogenic variant in the CYP27A1 gene. There is considerable variation in clinical characteristics and age of onset of this disease, including absence of tendon xanthomas, delaying the diagnosis. Early recognition and chronic chenodeoxycholic acid therapy can improve outcome and quality of life.
- 1 May 2019
- Published by SciELO Agencia Nacional de Investigacion y Desarrollo (ANID) in Revista médica de Chile
- Vol. 147 (5) , 658-662
Open AccessXantomatosis cerebrotendinosa sin xantomas tendíneos. Caso clínico
Cerebrotendinous xanthomatosis (CTX) is an uncommon autosomal recessive disease caused by deficiency of 27-sterol-hydroxylase that results in an accumulation of cholestanol in the central nervous system, eyes, tendons, and blood vessels. We report a 22-year-old woman with a history of cataract surgery at the age of 14, cholecystectomy due to cholelithiasis at the age of 17 and chronic diarrhea, who presented with a six months period of gait instability and frequent falls. Physical examination revealed a bilateral pyramidal and cerebellar syndrome, with no visible tendon xanthomas. Cerebral magnetic resonance imaging showed an increase of the signal intensity on the T2-weighted images in periventricular cerebral white matter, dentate nuclei and spinal cord. With a high suspicion of CXT, a genetic study was conducted identifying a pathogenic variant in the CYP27A1 gene. There is considerable variation in clinical characteristics and age of onset of this disease, including absence of tendon xanthomas, delaying the diagnosis. Early recognition and chronic chenodeoxycholic acid therapy can improve outcome and quality of life.
- 1 May 2019
- Published by Elsevier in Neuromuscular Disorders
- Vol. 29 (5) , 398-400
Wrist drop in an arcade dancing game: Unusual sudden bilateral radial palsy
- 1 May 2019
- Published by Elsevier in Neuromuscular Disorders
- Vol. 29 (5) , 398-400
Wrist drop in an arcade dancing game: Unusual sudden bilateral radial palsy